» Articles » PMID: 22798961

Regulation of PKC-θ Function by Phosphorylation in T Cell Receptor Signaling

Overview
Journal Front Immunol
Date 2012 Jul 17
PMID 22798961
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase C (PKC)-θ is a serine/threonine kinase belonging to the calcium-independent novel PKC subfamily; its expression is restricted to certain tissues and cell types, including T cells. The signals delivered from T cell receptor (TCR) and CD28 costimulatory molecules trigger PKC-θ catalytic activation and membrane translocation to the immunological synapse, leading to activation of NF-κB, AP-1, and NF-AT. These transcription factors are important for T cell survival, activation, and differentiation. Phosphorylation of PKC-θ at multiple Ser/Thr/Tyr residues is induced in T cells during TCR signaling. Some phosphorylation sites play critical roles in the regulation of PKC-θ function and downstream signaling. The regulation mechanisms for PKC-θ phosphorylation sites are now being revealed. In this review, we discuss the current understanding of the regulation of PKC-θ function by phosphorylation during TCR signaling.

Citing Articles

Mapping the SLP76 interactome in T cells lacking each of the GRB2-family adaptors reveals molecular plasticity of the TCR signaling pathway.

Ruminski K, Celis-Gutierrez J, Jarmuzynski N, Maturin E, Audebert S, Malissen M Front Immunol. 2023; 14:1139123.

PMID: 37006259 PMC: 10057548. DOI: 10.3389/fimmu.2023.1139123.


The Peptidyl-Prolyl isomerase, Pin1, associates with Protein Kinase C θ a critical Phospho-Thr-Pro motif in the V3 regulatory domain.

Anto N, Muraleedharan A, Nath P, Sun Z, Keasar C, Livneh E Front Immunol. 2023; 14:1126464.

PMID: 36969236 PMC: 10031136. DOI: 10.3389/fimmu.2023.1126464.


Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD.

Verstockt B, Verstockt S, Cremer J, Sabino J, Ferrante M, Vermeire S BMJ Open Gastroenterol. 2023; 10(1).

PMID: 36746519 PMC: 9906185. DOI: 10.1136/bmjgast-2022-001003.


Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment.

Gao Y, Hu S, Li R, Jin S, Liu F, Liu X JCI Insight. 2023; 8(4).

PMID: 36649072 PMC: 9977500. DOI: 10.1172/jci.insight.164793.


Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.

Levy R, Gothe F, Momenilandi M, Magg T, Materna M, Peters P J Exp Med. 2022; 220(2).

PMID: 36515678 PMC: 9754768. DOI: 10.1084/jem.20220275.


References
1.
Baier G, TELFORD D, Giampa L, Coggeshall K, Baier-Bitterlich G, Isakov N . Molecular cloning and characterization of PKC theta, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem. 1993; 268(7):4997-5004. View

2.
Liu Y, Witte S, Liu Y, Doyle M, Elly C, Altman A . Regulation of protein kinase Ctheta function during T cell activation by Lck-mediated tyrosine phosphorylation. J Biol Chem. 2000; 275(5):3603-9. DOI: 10.1074/jbc.275.5.3603. View

3.
Kong K, Yokosuka T, Canonigo-Balancio A, Isakov N, Saito T, Altman A . A motif in the V3 domain of the kinase PKC-θ determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat Immunol. 2011; 12(11):1105-12. PMC: 3197934. DOI: 10.1038/ni.2120. View

4.
Lee K, DAcquisto F, Hayden M, Shim J, Ghosh S . PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation. Science. 2005; 308(5718):114-8. DOI: 10.1126/science.1107107. View

5.
Benes C, Wu N, Elia A, Dharia T, Cantley L, Soltoff S . The C2 domain of PKCdelta is a phosphotyrosine binding domain. Cell. 2005; 121(2):271-80. DOI: 10.1016/j.cell.2005.02.019. View